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Vital Exhaustion and Somatic Depression: The Same Underlying Construct
in Patients With Myocardial Infarction?
ESTHER M. VROEGE, BSC, MARIJ ZUIDERSMA, PHD, AND PETER DE JONGE, PHD
Objective: To test whether vital exhaustion overlaps more with somatic/affective depression than with cognitive/affective de-
pressive symptoms and evaluate the risk of recurrent cardiovascular events associated with these constructs. Methods: The Beck
Depression Inventory (BDI) and the Maastricht Questionnaire (MQ) were administered to 528 patients hospitalized with myocardial
infarction (MI). Principal component analyses (PCAs) were performed to assess the structure of the BDI, the MQ, and both combined.
Univariate and multivariate (adjusting for age, sex, left ventricular ejection fraction, Killip Class, and history of MI) Cox proportional
hazard regression analyses were used to examine the risk of recurrent cardiovascular events associated with the subscales of the
MQ and of both questionnaires together. Results: PCA on the MQ yielded only one dimension. Per-standard-deviation increase in
total MQ score, the multivariate hazard ratio was 1.37 (conﬁdence interval [CI] = 1.15Y1.64, p G .001). PCA on the items of MQ and
BDI together yielded two dimensions: a somatic/affective and a cognitive/affective dimension. All but two of the items of the MQ
loaded on the somatic/affective dimension. The multivariate hazard ratio for recurrent events associated with a 1-standard deviation
increase in the somatic/affective dimension was 1.39 (CI = 1.11Y1.73, p = .004), which was higher than the risk associated with the
cognitive/affective dimension (1.02, CI = 0.82Y1.27, p = .83). Conclusions: Vital exhaustion and somatic/affective depression strongly
overlap and may cover the same underlying construct that increased the risk of new cardiovascular events. Key words: depression, vital
exhaustion, myocardial infarction, somatic/affective and cognitive/affective symptom dimension.
BDI = Beck Depression Inventory; CI = conﬁdence interval;HADS =
Hospital Anxiety and Depression Scale; HR = hazard ratio; LVEF =
left ventricular ejection fraction; MDD = major depressive disorder;
MI = myocardial infarction; MQ = Maastricht Questionnaire; PCA =
principal component analysis; SD = standard deviation.
INTRODUCTION
T he prevalence of depression in patients experiencing heartdisease is much higher than that in the general population
(1,2). Because heart disease and depression are predicted to be
the number 1 and 2 diseases contributing to the global burden
of disease by 2020 (3), it is essential that the relationship be-
tween the two is well understood.
Vital exhaustion has been developed as a construct describ-
ing symptoms of fatigue, irritability, and demoralization, both as
a precursor and as a consequence of acute coronary syndrome
(4,5). Like depression, vital exhaustion is a risk factor for the
development and progression of cardiovascular disease (6Y8), but
it is unclear to what extent it reﬂects the same underlying
mechanisms as depression. To date, studies evaluating the
overlap between depression and vital exhaustion have gener-
ated inconsistent results. Three studies found evidence sup-
porting a two-factor model in which depression and vital
exhaustion are two different concepts (9Y11). The ﬁrst study by
van Diest and Appels (11) in 1991 found the prevalence of
depressed mood to be very low in patients with vital exhaus-
tion. The second byKopp and colleagues (9) in 1998 found that
depression related more to psychiatric factors, whereas vital
exhaustion related more to cardiac disease factors. In 2004, the
third study by Kudielka and colleagues (10) performed a factor
analysis on a depression questionnaire and a short version of the
Maastricht Questionnaire (MQ) that assesses vital exhaustion and
found them to be representing different underlying constructs.
However, one other study byWojciechowski and colleagues (12)
in 2000 found strong correlations between scores on depression
questionnaires and the MQ.
A potential explanation for the discrepancies between ﬁnd-
ings from the ﬁrst three studies and this last study may be the
heterogeneity of depression. For instance, van Diest and Appels
(11) found vital exhaustion not to be related to depressed mood
but strongly related to the individual items ‘‘fatigability,’’ ‘‘work
inhibition,’’ ‘‘sleep disturbances,’’ and ‘‘loss of libido’’ of the
Beck Depression Inventory (BDI). Previously, we described two
different symptom dimensions of depression in patients with
MI: a somatic/affective and a cognitive/affective dimension (13).
Somatic/affective symptoms were found to be remarkably
stronger associated with recurrent cardiovascular events than
cognitive/affective symptoms, which was replicated in several
other studies (13Y15).
Also, vital exhaustion was found to be a heterogeneous
concept. In 3877 healthy men, Appels et al. (16) evaluated vital
exhaustion using the MQ, on which data they performed fac-
tor analysis. The factor analysis yielded a fatigue, a depressive
affect, and an irritability subscale. Of these, the fatigue sub-
scale was the strongest predictor of incident MI, and the de-
pression and irritability subscales lost their predictive value
after adjusting for fatigue. Studies appearing later, which per-
formed a factor analysis on the MQ, found the MQ to consist
of at least two dimensions (fatigue and depression) (17Y19).
The heterogeneity of vital exhaustion and particularly de-
pression could explain the inconsistent results of studies inves-
tigating the overlap between depression and vital exhaustion.
Evaluating the overlap between speciﬁc subscales of depression
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and subscales of vital exhaustion might give considerable un-
derstanding in the cardiotoxic components of psychosocial risk
factors for cardiovascular disease. In addition, this would help to
translate ﬁndings from both separate lines of research. To date, no
study evaluated the overlap between (dimensions of) vital ex-
haustion and speciﬁc depressive symptom dimensions in patients
with MI.
In this study, we therefore evaluated potential overlap be-
tween different subscales of the BDI and MQ in a sample of
patients with MI by performing factor analysis on all items of
both questionnaires together. We hypothesized that the items
of the MQ would overlap substantially more with somatic/
affective items of the BDI than cognitive/affective items. In ad-
dition, we evaluated the risk of recurrent cardiovascular events
associated with subscales of the BDI and the MQ obtained by
factor analysis. A previous publication, based on this sample,
showed that somatic/affective, but not cognitive/affective de-
pressive symptoms of the BDI, predicted new cardiovascular
events (13). In the present analysis, we evaluated the risk of new
cardiovascular events associated with symptom dimensions of
the MQ and symptom dimensions yielded by factor analysis
on the 42 items of the BDI and MQ together. In addition, we
evaluated the risk of new cardiovascular events associated with
individual items from the BDI and the MQ.
METHODS
Data from the Depression after Myocardial Infarction (DepreMI) study were
used. The methods of this study have been described in detail elsewhere (20Y22)
and are brieﬂy described in the next paragraphs.
Design and Patients
The DepreMI was a naturalistic follow-up study on the impact of depres-
sion on cardiac prognosis in patients with MI. Subjects were recruited from
four hospitals in the north of the Netherlands. From September 1997 and October
2000, all consecutive patients admitted for MI were assessed for eligibility. In-
clusion criteria, of which at least two had to be met, were a) chest pain for at least
20 minutes, b) creatinine phosphokinase levels 100% greater than normal or
creatinine phosphokinase MB levels greater than 10%, and c) presence of new
pathological Q waves on the electrocardiogram in at least two leads. Exclusion
criteria were life expectancy of less than a year because of noncardiac condi-
tion, too poor physical condition according to hospital staff, cognitive dys-
function, inability to speak or read Dutch, occurrence of an MI in patients
admitted for another reason, and follow-up visits scheduled in a nonparticipat-
ing hospital. All participating patients in the study signed an informed consent
form, and the ethics committee review board at all the participating hospitals
approved the study protocol.
Assessment of Depressive Symptoms and
Vital Exhaustion
Depressive symptoms were measured using the BDI (23). The BDI is a
widely used 21-item self-report measure assessing the presence and severity
of depressive symptoms. Participants were instructed to rate each symptom on
a scale from 0 to 3, with a score of 0 representing absence and scores 1 to 3
representing increasing levels of severity. Total scores can range from 0 to 63,
with a score of 10 or more indicating at least mild depressive symptoms.
Vital exhaustion was assessed using the MQ (4). The MQ is a 21-item
questionnaire, originally developed to identify future cases of coronary heart
disease (24). Each statement may be answered Yes, No, or Do Not Know, re-
sulting in a score from 0 to 2. Total scores range from 0 to 42, with a score of
14 or more suggesting signiﬁcant symptoms of vital exhaustion.
The MQ and the BDI were administered as a combined questionnaire (ﬁrst
MQ, then BDI) during hospitalization for index MI. Patients answered ques-
tions about the presence and severity of symptoms since the MI.
Assessment of Covariates
Age, sex, history of MI, Killip Class, left ventricular ejection fraction
(LVEF), site of the MI, body mass index, procedures during hospitalization for
index MI, history of peripheral and cerebral vascular disease, hypertension,
hypercholesterolemia, and the presence of diabetes mellitus were assessed from
hospital charts during hospital admission for index MI. Killip Class was assessed
with a standardized 4-point clinical assessment, based on pulmonary rales and
radiograph. LVEF was assessed by echocardiography, radionuclide ventriculog-
raphy, gated single photon emission computed tomography, magnetic resonance
imaging, angiography, or clinical assessment. Smoking status, living alone, and
education were evaluated in a face-to-face interview at 3 months after the MI.
Smokingwas deﬁned as current smoker or quit smoking less than 3months before
hospital admission.
Assessment of Recurrent Cardiovascular Events
Cardiovascular mortality and cardiovascular-related readmissions to the
hospital were obtained from hospital records and the participant’s primary care
physician. Cardiovascular-related readmissions included those for recurrent
MI, (un)stable angina, heart failure, arrhythmia, peripheral cardiovascular disease,
or cerebrovascular accident. An independent end point committee consisting of
two cardiologists evaluated whether potential end points were cardiovascular or
not. Discrepancies were discussed until consensus was achieved. Follow-up time
started at the index MI and lasted up until a) the occurrence of cardiovascular
complication and b) the end of follow-up time. Mean (standard deviation [SD])
follow-up time was 2.5 (0.9) years. Patients without an event were censored at
the end of follow-up date or the date of death (in case of noncardiac death).
Data Analyses
First, principal component analysis (PCA) with oblimin rotation was per-
formed on all 21 items of the BDI to obtain the symptom dimensions of de-
pression. Previously, we reported that this resulted in a somatic/affective, a
cognitive/affective, and an appetitive dimension (based on PCA on the BDI in
this patient sample combined with another sample of patients with MI) (13).
Next, PCA with oblimin rotation was performed on the 21 items of the MQ.
Finally, to evaluate potential overlap between dimensions of vital exhaustion
and dimensions of the BDI, PCAwas performed on the 42 items from the BDI
and MQ together. The optimal number of dimensions was determined based on
a scree-plot. Standardized total factor scores were calculated using the regres-
sion method.
Univariate and multivariate Cox proportional hazard regression analyses
were used to examine the risk of recurrent cardiovascular events associated
with a) the factor scores obtained from the PCA on the BDI an MQ separately,
b) the dimensions obtained from the PCA on the BDI and MQ together, and c)
the dichotomized scores on the individual items of the MQ (items scoring
‘‘do not know’’ where classiﬁed as absent) and the BDI (items scoring 1, 2, or 3
were classiﬁed as present; items scoring 0 were classiﬁed as absent). In mul-
tivariate analyses, adjustments were made for age, sex, and LVEF less than 40%




A total of 528 patients with MI gave informed consent. BDI
scores and MQ scores were present for 509 and 520 patients,
respectively. For 464 patients, data on whether they had recur-
rent cardiovascular events were present. Of these, 110 (23.7%)
had a recurrent cardiovascular event during a M (SD) follow-up
time of 2.03 (1.02) years (median = 2.15 years, range = 8 days
to 4.23 years). Table 1 shows the baseline characteristics for
the total group and for those with and without recurrent cardio-
vascular events separately. Compared with those who remained
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event-free, those with a recurrent cardiovascular event were sig-
niﬁcantly older, more often had anterior site MI, Killip Class
higher than 1, LVEF less than 40%, history of MI, peripheral
vascular disease, hypercholesterolemia, diabetes, less often had
CABG during hospitalization for index MI, and had higher total
scores on the BDI and MQ.
Structure of the BDI and MQ
PCA on the BDI yielded two dimensions, representing
somatic/affective and cognitive/affective symptoms, which is
comparable to what was previously reported on PCA based on
this patient sample combined with another sample of patients
with MI (13). In contrast to this previous analysis, which
resulted in a three-factor solution, the third (appetitive) di-
mension explained less of the variance, resulting in a two-factor
solution. The correlation between the somatic/affective and
cognitive/affective dimension was 0.42.
PCA on the 21 items of the MQ yielded only one dimen-
sion, which explained 35% of the variance.
PCA on the 42 items from both scales together yielded two
dimensions, which explained 34% of the variance together. The
ﬁrst was a somatic/affective dimension including the somatic/
affective items from the BDI and all items from the MQ, ex-
cept items 13 (giving up) and 16 (wish to be dead). The second
was a cognitive/affective dimension (including the cognitive/
affective items from the BDI and items 13 and 16 of the MQ).
Factor loadings of the PCA on the 42 items of both question-
naires together are shown in Table 2.
Symptom Dimensions of the BDI and MQ and
Recurrent Cardiovascular Events
The somatic/affective factor score of the BDI was a stronger
predictor for recurrent cardiovascular events than the cognitive/
affective factor score (unadjusted hazard ratio [HR] = 1.39 [95%
conﬁdence interval {CI} = 1.17Y1.65, p G .001] per SD increase,
multivariate HR= 1.35 [95%CI = 1.07Y1.72, p = .01], whichwas
1.18 [95% CI = 0.98Y1.42, p = .09] and 1.00 [95% CI =
0.77Y1.28, p = .98], respectively, for the cognitive/affective factor
score). This is comparable to what we reported previously for
somatic/affective and cognitive/affective depressive symptoms
obtained by PCA on the BDI of this patient sample combined
with another sample of MI patients (13). Because PCA on the
MQ yielded only one dimension, Cox regression was performed
on the total score of the MQ. Per SD increase on the MQ, the risk
of recurrent cardiovascular eventswas 1.37 (95%CI = 1.15Y1.64,
pG .001) in the univariate analysis and 1.33 (95%CI = 1.11Y1.60,
p = .002) in the multivariate analysis.
The HR for recurrent events associated with 1 SD increase
in the somatic/affective factor score from the PCA on all 42
items together was 1.45 (95% CI = 1.21Y1.75, p G .001), which
was 1.18 (95% CI = 0.98Y1.42, p = .08) for the cognitive/affec-
tive factor score in the univariate analyses. Inmultivariate analyses,
TABLE 1. Baseline Characteristics for the Total Sample and for Those With and Without New Events
Total Sample (n = 464) New Event (n = 110) No New Event (n = 354) pa
Age, M (SD), y 60.5 (11.7) 62.8 (11.2) 59.8 (11.7) .02
Female, n (%) 86 (18.5) 22 (20.0) 64 (18.1) .65
Living alone, n (%) 70 (15.1) 19 (17.3) 51 (14.4) .46
Primary school only, n (%) 90 (19.4) 23 (20.9) 67 (18.9) .65
Anterior site of MI, n (%) 148 (31.9) 45 (40.9) 103 (29.1) .02
Killip Classb 9 1, n (%) 64 (13.9) 24 (22.0) 40 (11.3) .005
LVEF G 40%,b n (%) 107 (23.1) 33 (30.3) 74 (20.9) .04
Thrombolysis during hospitalization for index MI,b n (%) 204 (44.2) 51 (46.4) 153 (43.5) .59
PTCA during hospitalization for index MI,b n (%) 103 (25.4) 21 (21.6) 82 (26.5) .33
CABG during hospitalization for index MI, n (%) 14 (3.4) 0 (0.0) 14 (4.5) .03
History of MI, n (%) 64 (13.8) 25 (22.7) 39 (11.0) .002
History of cerebrovascular disease, n (%) 21 (4.5) 7 (6.4) 14 (4.0) .29
History of peripheral vascular disease, n (%) 31 (6.7) 16 (14.5) 15 (4.2) G.001
History of hypertension, n (%) 128 (27.6) 30 (27.3) 98 (27.7) .93
History of hypercholesterolemia, n (%) 161 (34.7) 47 (42.7) 114 (32.2) .04
History of diabetes, n (%) 47 (10.1) 18 (16.4) 29 (8.2) .01
Family history of coronary artery disease, n (%) 174 (37.5) 47 (42.7) 127 (35.9) .20
Smoking at the time of index MI, n (%) 222 (52.6) 56 (54.9) 166 (51.9) .59
BMI,b M (SD), kg/m2 26.8 (4.0) 26.9 (4.3) 26.4 (3.2) .25
BDI at hospitalization, IQR 3, 5, 9 3, 6, 13 2, 5, 9 G.001
MQ at hospitalization, IQR 5, 12, 22 9, 16, 25 5, 11, 20 .004
M =mean; SD = standard deviation; MI = myocardial infarction; LVEF = left ventricular ejection fraction; PTCA = percutaneous transluminal coronary intervention;
CABG = coronary artery bypass grafting; BMI = body mass index; BDI = Beck Depression Inventory; IQR = interquartile range; MQ = Maastricht Questionnaire.
a The p value was based on W2 for dichotomous variables, independent-sample t test for age and BMI, and Mann-Whitney U for the BDI and MQ scores.
b Killip Class, n = 462; LVEF, n = 463; thrombolysis, n = 462; PTCA, n = 406; CABG, n = 406; smoking, n = 422; BMI, n = 383.
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this was 1.39 (95% CI = 1.11Y1.73, p = .004) and 1.02 (95% CI =
0.82Y1.27, p = .83), respectively. Figure 1 shows Kaplan-Meier
curves showing the risk of recurrent cardiovascular events for the
20% of patients scoring highest on the somatic/affective and
cognitive/affective dimensions from the BDI and MQ together.
Individual Items of the BDI and MQ and Recurrent
Cardiovascular Events
Figure 2 shows the age- and sex-adjusted HRs (95% CI) for
recurrent cardiovascular events associated with the presence of
the individual items from the BDI and MQ. Most items posed
an increased risk (HRs ranging from 0.68 to 1.88 for the BDI
and from 1.05 to 2.02 for the MQ). The increased risk associ-
ated with the somatic/affective dimension could not be attrib-
uted to one or a few speciﬁc items. Furthermore, the difference
between the somatic/affective and cognitive/affective dimen-
sion in cardiovascular risk was not clearly reﬂected in the indi-
vidual items.
DISCUSSION
The present study examined the relationship between spe-
ciﬁc components of vital exhaustion and depression and their
association with cardiovascular prognosis. Factor analysis on
the MQ yielded only one dimension in patients with MI. Factor
analysis on the items of the MQ and BDI together yielded two
dimensions: a somatic/affective and a cognitive/affective di-
mension. All items but two from the MQ loaded on the somatic/
affective dimension, which was more strongly associated with
worse prognosis than the cognitive/affective dimension. These
results suggest that vital exhaustion and somatic/affective de-
pression reﬂect the same underlying construct that increases
the risk of new cardiovascular events.
This study has several strengths. The large sample size and
large number of patients with a recurrent cardiovascular event
make it possible to perform factor analysis and multivariate
Cox regression analysis respectively without creating bias. A
limitation of the present ﬁndings is that it is not clear to what
extent they can be generalized to other populations, such as
healthy individuals or patients with other cardiovascular or
noncardiovascular diseases. Furthermore, the interpretation of
the present analysis may not be extended to other depression
questionnaires than the BDI. The BDI includes a relatively
large proportion of somatic/affective depressive symptoms,
whereas other questionnaires, such as the Hospital Anxiety and
Depression Scale (HADS), include relatively more cognitive/
affective depressive symptoms.
This was the ﬁrst study that examined the overlap between
depression and vital exhaustion while taking into account the
heterogeneity of depression. We found that vital exhaustion
overlaps with the somatic/affective dimension of depression
rather than depression as a whole. Because there are differences
between depression questionnaires in the proportion of somatic/
affective depressive symptoms, the use of different depression
questionnairesmay explain the discrepant results between studies
evaluating the overlap between vital exhaustion and depression.
For instance, Kudielka et al. (10) evaluated the overlap between
the HADS and a nine-item version of the MQ by performing
factor analysis on the items of both questionnaires together.
Because the HADS consists mainly of cognitive/affective
depressive symptoms and the version of the MQ they used
consists only of fatigue-related symptoms, it is not surprising














Suicidal ideas 0.103 0.365
Crying 0.369 0.106
Irritability 0.124 0.488
Social withdrawal 0.467 0.174
Indecisiveness 0.093 0.217
Body image change 0.642 0.090
Work difficulty 0.443 0.159
Insomnia 0.615 0.012
Fatigability 0.482 0.134
Loss of appetite 0.323 0.141
Weight loss 0.314 0.331
Somatic preoccupation 0.378 0.202
Loss of libido 0.378 0.202
MQ 0.776 0.125
Often feel tired 0.324 0.118
Difficulties falling asleep 0.404 0.012
Often wake up at night 0.171 0.068
Feel altogether weak 0.696 0.193
Not accomplish much 0.617 0.063
Becomes all too much 0.460 0.294
Have come to a dead end 0.659 0.128
Lately feel listless 0.427 0.043
Loss of libido 0.413 0.330
Feelings of hopelessness 0.520 0.005
Difficulties comprehending 0.390 0.179
Little things irritate more 0.159 0.541
Want to give up 0.674 0.042
Feel fine (no) 0.625 0.010
Body like battery running out 0.095 0.598
Sometimes wish to be dead 0.562 0.089
Worthlessness 0.427 0.429
Feel dejected 0.329 0.258
Sometimes feel like crying 0.450 0.203
Ever wake up exhausted 0.611 0.013
Difficulties concentrating 0.611 0.013
BDI = Beck Depression Inventory; MQ = Maastricht Questionnaire.
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that they found depression and vital exhaustion to represent two
distinct dimensions.
In the present study, factor analysis on the MQ yielded only
one dimension. In contrast, Appels et al. (16) found in a sample
of healthy men three dimensions, comprising fatigue, depres-
sion, and irritability, respectively. McGowan et al. (17) found
the following dimensions in a sample of 305 patients with MI:
fatigue, depression, lack of concentration, and sleeping prob-
lems, explaining 18.2%, 17.9%, 9.5%, and 8.1% of the vari-
ance, respectively. Pedersen et al. (18) found in a sample of
patients with unstable and stable angina a depression and a
fatigue dimension. Contrary to the results from the present
study, they found the depression dimension, but not fatigue, to
be predictive of recurrent cardiovascular events, with hopeless-
ness as the most cardiotoxic depressive symptom. The differ-
ence with the ﬁndings of the present study may be explained by
relatively small number of patients with adverse outcome in their
study (i.e., 31 in their study versus 110 in the present study).
Smith et al. (19) found in a sample patients with of chronic heart
failure four dimensions representing fatigue, cognitive/affective
depressive symptoms, sleep difﬁculties, and lack of concentra-
tion. It is worth mentioning that, in the present study, (cognitive)
depression, sleeping problems, and irritability/lack of con-
centration dimensions explained most variance in the second
(8%), third (6%), and fourth (5%) place. Therefore, the factor
structure of the MQ in the present study is similar to those
reported in other studies.
This was the ﬁrst study that performed a factor analysis of
the BDI and MQ together. Previously, Wojciechowski et al. (12)
performed factor analysis on the Zung-SDS, the Depression Scale
of the SCL-90 and the MQ, which yielded one dimension. This
ldiscrepancy may be explained by the smaller sample size of
Wojciechowski et al. (12).
The individual item analysis did not reveal speciﬁcally
cardiotoxic items/symptoms. Instead, most symptoms posed an
increased risk (Fig. 2). This ﬁnding is consistent with that of
Figure 1. Event-free survival after MI and relationship to somatic/affective symptoms and cognitive/affective symptoms obtained by PCA on the 42 items of the
BDI and MQ together.
Figure 2. Risk of recurrent cardiovascular events for individual items of the BDI and MQ adjusted for age and sex.
E. M. VROEGE et al.
450 Psychosomatic Medicine 74:446Y451 (2012)
a previous study in more than 10,000 healthy individuals, re-
porting an increased risk of incident MI or mortality associ-
ated with each individual item from the MQ (25). In fact, the
difference between the somatic/affective and cognitive/affective
dimension in cardiotoxicity was not clearly reﬂected in the in-
dividual items. We therefore conclude that the cardiotoxic ef-
fect of somatic/affective symptoms is due to the combination
of symptoms rather than one or a few speciﬁc symptoms.
Findings from the present study suggest that vital exhaus-
tion and somatic/affective depression cover the same concept,
which is particularly associated with poor cardiac outcomes.
This concept may be different from major depressive disorder
(MDD) because patients experiencing vital exhaustion do not
necessarily need to fulﬁll all criteria for MDD (11) and, simi-
larly, somatic symptoms of depression can be present in the
absence of a diagnosis of MDD. In fact, vital exhaustion or so-
matic/affective depressive symptoms may even be a more accu-
rate predictor of cardiovascular prognosis than depression as a whole.
Although the increased risk associated with somatic/
affective depression and vital exhaustion was independent from
several parameters of cardiac disease severity, other mecha-
nisms may explain the association. For instance, ﬁndings from
some studies suggest that inﬂammation may underlie the vital
exhaustion and somatic depression in patients with MI. Janszky
and colleagues (26) found that, in women with coronary heart
disease, vital exhaustion showed an association with inﬂamma-
tion measured, whereas depression did not. In other studies, de-
pression was associated with inﬂammation, which has been
proposed as one of the pathways between depression and poor
cardiac outcomes (27). For instance, Dantzer and colleagues
(28) reported a direct increase particularly in somatic depres-
sion after cytokine immunotherapy in patients treated for cancer
or hepatitis C.
In conclusion, the present study revealed that vital exhaus-
tion and somatic/affective depression show a strong overlap, im-
plicating that they both represent an underlying concept, which
is particularly associated with poor cardiovascular outcomes.
The authors thank all participating patients and the hospital staff
of the participating hospitals.
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